Literature DB >> 1997476

5-Hydroxytryptamine (serotonin) subtype 3 antagonists, a major step in prophylaxis and control of cytostatic and radiation-induced emesis.

K Bremer1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1997476     DOI: 10.1007/bf01613203

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


× No keyword cloud information.
  22 in total

1.  Pharmacological analysis of the effects of metoclopramide on the guinea-pig ileum in vitro.

Authors:  J Fontaine; J J Reuse
Journal:  Arch Int Pharmacodyn Ther       Date:  1973-08

2.  Efficacy of ondansetron (GR 38032F) and the role of serotonin in cisplatin-induced nausea and vomiting.

Authors:  L X Cubeddu; I S Hoffmann; N T Fuenmayor; A L Finn
Journal:  N Engl J Med       Date:  1990-03-22       Impact factor: 91.245

3.  The role of specific 5-HT3 receptor antagonism in the control of cytostatic drug-induced emesis.

Authors:  P R Blower
Journal:  Eur J Cancer       Date:  1990       Impact factor: 9.162

4.  A comparative study of the use of granisetron, a selective 5-HT3 antagonist, versus a standard anti-emetic regimen of chlorpromazine plus dexamethasone in the treatment of cytostatic-induced emesis. The Granisetron Study Group.

Authors:  M Marty
Journal:  Eur J Cancer       Date:  1990       Impact factor: 9.162

5.  Efficacy and safety of granisetron compared with high-dose metoclopramide plus dexamethasone in patients receiving high-dose cisplatin in a single-blind study. The Granisetron Study Group.

Authors:  B Chevallier
Journal:  Eur J Cancer       Date:  1990       Impact factor: 9.162

6.  An overview on the use of granisetron in the treatment of emesis associated with cytostatic chemotherapy.

Authors:  M V Tabona
Journal:  Eur J Cancer       Date:  1990       Impact factor: 9.162

7.  Optimising antiemesis in cancer chemotherapy: efficacy of continuous versus intermittent infusion of high dose metoclopramide in emesis induced by cisplatin.

Authors:  P S Warrington; S G Allan; M A Cornbleet; J S MacPherson; J F Smyth; R C Leonard
Journal:  Br Med J (Clin Res Ed)       Date:  1986-11-22

8.  Blockade of neuronal tryptamine receptors by metoclopramide.

Authors:  J R Fozard; A T Mobarok ALI
Journal:  Eur J Pharmacol       Date:  1978-05-01       Impact factor: 4.432

9.  Extrapyramidal reactions with metoclopramide.

Authors:  D N Bateman; M D Rawlins; J M Simpson
Journal:  Br Med J (Clin Res Ed)       Date:  1985-10-05

10.  Ondansetron (GR38032F) plus dexamethasone: effective anti-emetic prophylaxis for patients receiving cytotoxic chemotherapy.

Authors:  D B Smith; E S Newlands; O W Spruyt; R H Begent; G J Rustin; B Mellor; K D Bagshawe
Journal:  Br J Cancer       Date:  1990-02       Impact factor: 7.640

View more
  2 in total

Review 1.  Role of serotonin in the pathogenesis of acute and chronic pulmonary hypertension.

Authors:  P Egermayer; G I Town; A J Peacock
Journal:  Thorax       Date:  1999-02       Impact factor: 9.139

Review 2.  A systematic review of methodologies, endpoints, and outcome measures in randomized trials of radiation therapy-induced nausea and vomiting.

Authors:  Kristopher Dennis; Rehana Jamani; Clare McGrath; Leila Makhani; Henry Lam; Patrick Bauer; Carlo De Angelis; Natalie Coburn; C Shun Wong; Edward Chow
Journal:  Support Care Cancer       Date:  2017-03-31       Impact factor: 3.603

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.